Derivation of Mesenchymal Stem Cells from Induced Pluripotent Stem Cells and Their Application in Genetic Disease Modeling 2307485
The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)
DOI: 10.1093/jimmun/vkag141.1378 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Giuseppe Sangiorgio und 15 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Thymic stromal cells are essential for T-cell progenitor proliferation and differentiation. While thymic epithelial cells are well studied, non-epithelial stromal populations–particularly neural crest—derived mesenchymal cells–are increasingly recognized for their roles in thymus formation and function. Mesenchymal defects contribute to thymic abnormalities in congenital syndromes such as DiGeorge syndrome (DGS), CHARGE syndrome, and Trisomy 21 (T21), yet human studies are limited by the rarity of these conditions and restricted access to thymic tissue.
Methods
We generated iPSCs from individuals with TBX1, CHD7, HOXA3, and PAX1 mutations, as well as DGS and T21 patients. Control and patient iPSCs, derived from PBMCs or skin biopsies, were differentiated into mesenchymal stem cells (MSCs). Primary thymic mesenchymal cells (ThyMCs) were also isolated from human thymi. All cell populations were analyzed by flow cytometry and bulk RNA-seq. Tri-lineage differentiation assays (adipogenic, chondrogenic, osteogenic) were performed to assess functional pathway defects.
Results
Flow cytometry confirmed robust expression of MSC markers (CD73, CD146, CD105) in all MSC and ThyMC samples, absent in undifferentiated iPSCs. Principal component analysis revealed clear segregation of iPSCs, MSCs, and ThyMCs. Transcriptomic profiling showed that all patient-derived MSCs acquired mesenchymal identity, but each disease group displayed distinct transcriptional changes. MSCs with TBX1, HOXA3, or PAX1 mutations had the highest number of differentially expressed genes, affecting pathways such as extracellular matrix and cartilage development.DGS-derived MSCs and ThyMCs showed marked upregulation of ECM and collagen genes (FBLN5, PCOLCE, EMILIN1, COL3A1, COL1A2).
Conclusion
Our findings reveal disease-specific mesenchymal defects underlying thymic abnormalities in congenital syndromes.This platform enables mechanistic studies of thymic stromal dysfunction and advances understanding of immune deficits in these disorders. Funding Source This work was supported by the Division of Intramural Research, NIAID, NIH. Topic Categories Hematopoiesis and Immune System Development (HEM)
Zitieren
APA
Sangiorgio, G., Pala, F., Amini, K., Anaya, E., Dinges, S., Delmonte, O. M., Freeman, A., Kreins, A. Y., Davies, E. G., Bernuth, H. V., Collins, C., Morena, M. T. D. L., Rathkopf, M. M., Bogunovic, D., Bosticardo, M., & Notarangelo, L. D. (2026). Derivation of Mesenchymal Stem Cells from Induced Pluripotent Stem Cells and Their Application in Genetic Disease Modeling 2307485. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1378
Vancouver
Sangiorgio G, Pala F, Amini K, Anaya E, Dinges S, Delmonte OM, et al. Derivation of Mesenchymal Stem Cells from Induced Pluripotent Stem Cells and Their Application in Genetic Disease Modeling 2307485. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1378
BibTeX
@article{Sangiorgio2026,
author = {Sangiorgio, Giuseppe and Pala, Francesca and Amini, Kayla and Anaya, Eduardo and Dinges, Sarah and Delmonte, Ottavia M and Freeman, Alexandra and Kreins, Alexandra Y and Davies, E Graham and Bernuth, Horst von and Collins, Cathleen and Morena, Maria Teresa de la and Rathkopf, Melinda M and Bogunovic, Dusan and Bosticardo, Marita and Notarangelo, Luigi D},
title = {Derivation of Mesenchymal Stem Cells from Induced Pluripotent Stem Cells and Their Application in Genetic Disease Modeling 2307485},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {Supplement_1},
doi = {10.1093/jimmun/vkag141.1378}
}
EUVIMED